Communiqués de presse
ExacTrac® X-Ray Defines the Standard in Intra-Fraction Motion Management
Increasing clinical adoption of cranial and spinal radiosurgery drives necessity for X-ray-based patient monitoring systems
San Francisco, September 12, 2014 – Brainlab, a global leader in medical technology, today announced the installation of the 625th ExacTrac® X-Ray. ExacTrac X-Ray provides submillimetric precison and a unique approach for solving the complexities associated with intra-fractional patient motion by internally verifying the patient’s position with stereoscopic X-Ray at the time of treatment, even at non-coplanar couch positions. ExacTrac X-Ray monitoring is especially valuable for cranial stereotactic radiosurgery (SRS) and spinal stereotactic body radiation therapy (SBRT) treatments.
“ExacTrac X-Ray monitoring defines the standard in intra-fractional motion management,” said Josh Yamada, MD, Radiation Oncologist, Memorial Sloan Kettering Cancer Center. “We can set up our patients using cone-beam CT or ExacTrac X-Ray, depending upon the patient’s needs. However, during treatment delivery, the need to manage intra-fractional motion at a high frequency is well met by ExacTrac X-Ray monitoring. The system has helped us overcome the challenges and complexities of spine radiosurgery cases. Overall, ExacTrac X-Ray monitoring provides an improvement to our setup accuracy and safe, efficient treatment delivery.”
Clinicians are able to use ExacTrac X-Ray technology for patient setup as well as patient monitoring throughout treatment delivery. ExacTrac X-Ray is unique because it allows the continuous verification of the patient’s position—at any point during treatment—based on internal anatomy and regardless of technique or couch position.
“With the increasing clinical adoption of frameless cranial and single fraction spinal radiosurgery treatments, the demand for ExacTrac X-Ray monitoring only increases, as witnessed by the 625th installation at Hartford Hospital in Connecticut,” said Stefan Vilsmeier, President and CEO, Brainlab. “This clinical adoption highlights the critical need for patient motion mangement during SRS and SBRT treatment delivery. Brainlab is continuously listening to our network of clincians and providing innovative solutions that faciliate the ability to safely and accurately treat SRS and SBRT patients.”
ExacTrac can be installed on any linear accelerator system complementing the LINAC with the unique ability to detect intra-fractional motion based on the patient’s internal anatomy. Today, over one million frameless radiosurgery treatments have been performed with ExacTrac X-Ray, evidence that leading institutions worldwide have confidence and trust in the benefits of the system. ExacTrac is utilized by half of the Top 50 cancer centers in the US (as ranked by the 2013-14 US News & World Report1).
For more information, visit brainlab.com/exactrac.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatment.
Core products revolve around information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology currently powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedics, ENT, CMF, spine and trauma.
Privately held since its formation in 1989, Brainlab has more than 5,000 systems installed in about 95 countries. Brainlab employs 1200 people in 17 offices worldwide, including 290 research & development engineers, who form a crucial part of the product development team.
To learn more, visit brainlab.com.